Quantum 1 Cannabis Signs Purchase Agreement to Open Flagship Location Near Oakridge …

May 6 th , 2021 – TheNewswire – Vancouver, BC – Quizam Media Corporation with Canna-Place to acquire an approved, municipal cannabis retail location in one of Vancouver ’ s most diverse neighborhoods at 41 st and Cambie Street in Vancouver, BC.

Under the terms of the new agreement, Quantum 1 has secured and finalized a prime location to move its development permit from a basement location to a higher traffic ground floor space.

“ With the recent financial announcement of record sales growth across our chain of unique cannabis stores, this flagship location expands our footprint in the Lower Mainland and has exceptional potential for growth.

We consider every product, every service offering in our stores as forms of energy that can heighten our own energies and in turn our collective world.

This news release may contain forward-looking statements including but not limited to comments regarding the timing and nature of potential acquisitions, joint ventures, partner ships, business dealings and financings, etc.

over PR Newswire, we are advised by the company that the 1st paragraph, 1st sentence, should read “8:00AM Eastern Time” rather than “5:00 AM Eastern Time” as originally issued inadvertently.

Harvest Health & Recreation Inc.

Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries.

, a vertically integrated cannabis company and multi-state operator in the U.S., today announced that it will hold a conference call on Monday, May 10, 2021 at 5:00 AM Eastern Time following the release of its first quarter 2021 financial results.

Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S.

Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products.

Its Wellbeing Products unit launched the first branded CBD skincare brand in Colombia , with Kuida™ now marketed in multiple jurisdictions in Latin America , the US and United Kingdom .

All information contained herein that is not historical in nature may constitute forward-looking information, including without limitation, statements relating to the Company’s anticipated sales and operations in Brazil and Mexico , the opening of additional satellite clinics and locations in Colombia , the effects of the Company’s first shipment of medical cannabis live plant material to Europe from Colombia , the ability of specialists to prescribe smaller quantities of medical cannabis flower products, the Company’s growth expectations and strategic plans.

These include the risk factors discussed in Khiron’s most recently filed annual information form, which is available on Khiron’s SEDAR profile at www.sedar.com .

The Supplier will provide a high-quality economical source of hemp biomass which Nextleaf Labs will process into refined and distilled CBD oils using Nextleaf’s patented extraction and purification platform.

“We are very pleased to work with a reputable, B.C.-based partner who has a nationwide network of validated CBD rich hemp farms to meet our increasing demand,” stated Nextleaf CFO, Charles Ackerman.

Through its wholly-owned subsidiary Nextleaf Labs Ltd, a licensed processor, the Company is a low-cost producer of cannabis distillate and private label THC & CBD oils.

All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements.

This milestone represents a turning point for BioHarvest as it brings its flagship product to the United States, the largest market in the world for nutraceutical supplements.

VINIA® is the first and only product in the world to contain Piceid Resveratrol from red grapes at levels in each capsule which is equivalent to the amount of Piceid Resveratrol in an average bottle of red wine, bringing consumers the benefits of red wine with the advantage of zero calories, zero sugar, and zero percent alcohol.

“We are entering the US nutraceuticals market with a powerful science-based product which has the ability to contribute to the overall wellness of American consumers.” said Ilan Sobel, CEO of BioHarvest, adding “Not only are we uniquely positioned to lead the established Resveratrol-based dietary supplements market, but we will also reach sizeable segments within this market, due to the heart health and energy enhancing benefits of VINIA®.

Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.‘s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes.

Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

…Read the full story